• Profile
Close

Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trial

American Journal of Otolaryngology - Head and Neck Medicine and Surgery May 04, 2020

Chang WT, Zee B, Lee HSH, et al. - In this prospective, multicentered, randomized controlled trial involving 56 patients, researchers sought to compare different means of intratympanic steroid delivery in the treatment of idiopathic sudden sensorineural hearing loss. Participants in the study were patients who fulfilled the inclusion criteria for idiopathic sudden sensorineural hearing loss who failed or were contraindicated for oral steroids. According to delivery methods, study participants were randomly divided into two groups: group A received 4 sections of intratympanic dexamethasone injection and group B received grommet placement with dexamethasone delivery followed by 3 sections of dexamethasone ear drop application. No statistical significance was observed between both groups in hearing threshold improvement. Grommet placement followed by the application of dexamethasone eardrop is a reasonable option for a patient indicated for intratympanic steroid, with lower medical cost, shorter waiting times and greater satisfaction.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay